Exendin agonist peptides
US7220721B1 · kind B1 · utility
61Cited by
3References
75Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 1998 |
| Grant date | May 22, 2007 |
| Priority date | — |
| Expiry date | Nov 13, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel exendin agonist compounds are provided. These compounds are useful in treating diabetes and conditions which would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.